Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06104033

Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease

Sponsor: Bon-Kwon Koo

View on ClinicalTrials.gov

Summary

This study is a prospective, multicenter, open-label, observational study to investigate the impact of using drug-coated balloons (DCBs) in the treatment of coronary artery lesions in patients with multivessel coronary artery disease (MVD), as opposed to the default strategy of using only drug-eluting stents (DES). The investigators aim to assess changes in clinical practice towards a hybrid treatment strategy (DES and DCB) and its effects on clinical outcomes.

Key Details

Gender

All

Age Range

19 Years - 100 Years

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2023-09-18

Completion Date

2026-10-31

Last Updated

2023-10-27

Healthy Volunteers

No

Interventions

DEVICE

drug-coated balloon

For the procedure, the drug-coated balloon (Agent®, Boston Scientific, USA) that can be used for both de-novo coronary lesions and in-stent restenosis lesions is used.

DEVICE

drug-eluting stent

When using drug-eluting stents, the latest 2nd generation drug-eluting stent (Synergy®, Boston Scientific, USA) should be used in accordance with the latest guidelines.

Locations (1)

Bon-Kwon Koo

Seoul, South Korea